Serum Matrix Metalloproteinase-2 as a Prognostic Marker in Advanced Cutaneous Melanoma

The association was studied between serum concentration of matrix metalloproteinase-2 (MMP-2) and metastatic site, survival and disease progression in patients with advanced cutaneous melanoma. The patient population consisted of 50 patients who were treated with chemoimmunotherapy. The median basel...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Acta oncologica 2000, Vol.39 (7), p.877-879
Hauptverfasser:	VUORISTO, Meri-Sisko, KELLOKUMPU-LEHTINEN, Pirkko, PARVINEN, Leena-Maija, HAHKA-KEMPPINEN, Marjo, KORPELA, Merja, KUMPULAINEN, Eero, LAINE, Seppo
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biological and medical sciences Biomarkers, Tumor - analysis Dermatology Disease Progression Female Humans Immunotherapy Male Matrix Metalloproteinase 2 - blood Matrix Metalloproteinase 2 - metabolism Medical sciences Melanoma - enzymology Melanoma - pathology Melanoma - therapy Middle Aged Prognosis Sensitivity and Specificity Skin Neoplasms - enzymology Skin Neoplasms - pathology Skin Neoplasms - therapy Survival Analysis Tumors of the skin and soft tissue. Premalignant lesions
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!